Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells

被引：0
|
作者：
Feifei Xu
Fengliang Wang
Ting Yang
Yuan Sheng
Ting Zhong
Yun Chen
机构：
[1] Nanjing Medical University,School of Pharmacy
[2] Nanjing Maternity and Child Health Care Hospital,undefined
来源：
Cancer Cell International | / 14卷
关键词：
Multi-drug Resistance Acquisition (MDR); P-glycoprotein (P-gp); Drug-specific; Doxorubicin (DOX); Paclitaxel (PTX);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Loss of APC mediates doxorubicin resistance in breast cancer cells
    Stefanski, Casey D.
    Keffler, Kaitlyn
    McClintock, Stephanie
    Prosperi, Jenifer R.
    CANCER RESEARCH, 2018, 78 (13)
  • [22] Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization
    Lou, Pei-Jen
    Lai, Ping-Shan
    Shieh, Ming-Jium
    MacRobert, Alexander J.
    Bergs, Kristian
    Bown, Stephen G.
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (11) : 2692 - 2698
  • [23] The Complex Dynamic of Phase I Drug Metabolism in the Early Stages of Doxorubicin Resistance in Breast Cancer Cells
    Barata, Isabel S.
    Gomes, Bruno C.
    Rodrigues, Antonio S.
    Rueff, Jose
    Kranendonk, Michel
    Esteves, Francisco
    GENES, 2022, 13 (11)
  • [24] Paclitaxel plus doxorubicin in breast cancer: An Italian experience
    Frassineti, GL
    Zoli, W
    Silvestro, L
    Serra, P
    Milandri, C
    Tienghi, A
    Gianni, L
    Gentile, A
    Salzano, E
    Amadori, D
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 19 - 25
  • [25] Optimal dosing of paclitaxel and doxorubicin in metastatic breast cancer
    Hortobagyi, GN
    Holmes, FA
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S4 - S7
  • [26] Combination chemotherapy with paclitaxel and doxorubicin for metastatic breast cancer
    Hortobagyi, GN
    Holmes, FA
    Theriault, RL
    Rahman, Z
    Buzdar, AU
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 13 - 19
  • [27] Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide for metastatic breast cancer -: In reply
    Jassem, J
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) : 3441 - 3442
  • [28] Resistance to Intervention: Paclitaxel in Breast Cancer
    Dan, Vipin Mohan
    Raveendran, Reji Saradha
    Baby, Sabulal
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (10) : 1237 - 1268
  • [29] A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer
    Bu, Huihui
    He, Xinyu
    Zhang, Zhiwen
    Yin, Qi
    Yu, Haijun
    Li, Yaping
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 471 (1-2) : 206 - 213
  • [30] Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells
    Latorre, Elisa
    Tebaldi, Toma
    Viero, Gabriella
    Sparta, Antonino Maria
    Quattrone, Alessandro
    Provenzani, Alessandro
    MOLECULAR CANCER, 2012, 11
12345